Dr. Christine Lee Hann, MD, PhD

Dr. Hann practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Hann's NPI, 1336295021, was assigned on January 26, 2007. Dr. Hann graduated from Jefferson Medical College of Thomas Jefferson University in 2000. Dr. Hann holds Maryland license D60372.

Dr. Hann's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Hann's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Hann is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Hann to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hann practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hann's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hann is licensed in Maryland.

CMS data shows 309 Medicare services from Dr. Hann across 4 procedure codes in 2024, for 119 Medicare patients. Medicare paid $32,026 for them.

CMS counts 119 Medicare patients who saw Dr. Hann in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have cancer, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hann's median patient age at 72, with 54% women.

In 2024, Dr. Hann wrote 91 Medicare Part D claims for 30 patients. 76% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $402 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hann for performance year 2024, reported as part of a group. CMS lists Dr. Hann as offering telehealth.

Dmand AI links 64 papers to Dr. Hann, published from 2013 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Small Cell Lung Carcinoma. Dr. Hann has published most often in Mol Cancer Ther. Dr. Hann's most frequent co-authors are Patrick Forde, MD, Josephine Feliciano, MD and David S. Ettinger, MD.

CMS Open Payments shows 102 general payments to Dr. Hann from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 73% of the total. Abbvie Inc. paid the most, $35,119. It also lists 10 research payments totaling $970 from 2016 to 2018.

Dr. Hann graduated from Jefferson Medical College of Thomas Jefferson University in 2000.